Secondary objectives included assessing the influence of neutropenia on the outcome of critically ill patients in pre-specified subgroups [according to the underlying tumor, period of admission, need for mechanical ventilation, and use of granulocyte colony-stimulating factor (G-CSF)]. The gene discussed is CSF3; the disease is neoplasm.